How Analysts and Investors Are Chasing Clovis Higher and Higher, All Over Again

0 Comments 6 view(s)

Clovis Oncology shares saw a massive gain on Tuesday, on the heels of news that the FDA had granted it a priority review of its cancer drug.

Powered by WPeMatico